Siemens AG ADR Stock
Siemens AG ADR Stock
The price for the Siemens AG ADR stock decreased slightly today. Compared to yesterday there is a change of -€1.000 (-0.700%).
So far the community has only identified positive things for Siemens AG ADR stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Siemens AG ADR in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Siemens AG ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Siemens AG ADR | -0.700% | 2.174% | 1.439% | 30.556% | 21.552% | 91.837% | 101.429% |
| Wartsila B | - | -2.403% | -8.339% | 22.292% | -3.721% | 165.456% | 129.423% |
| Siam Cement Pcl Fgn | - | 3.053% | 6.299% | 26.168% | 31.068% | -18.675% | -35.714% |
| Hitachi Ltd Adr/10 | -5.160% | 1.379% | 9.701% | 16.667% | 13.077% | -74.872% | -68.216% |
Comments
Shoulder Innovations (SI) is now covered by UBS Group AG. They set a "buy" rating and a $27.00 price target on the stock.
Show more
Ratings data for SI provided by MarketBeat
Shoulder Innovations (SI) had its "overweight" rating reaffirmed by Piper Sandler.
Show more
Ratings data for SI provided by MarketBeat
Shoulder Innovations (SI) had its price target raised by BTIG Research from $23.00 to $24.00. They now have a "buy" rating on the stock.
Show more
Ratings data for SI provided by MarketBeat
News
Siemens Aktiengesellschaft Q3 Earnings Call Highlights
Key Points
- Interested in Siemens Aktiengesellschaft? Here are five stocks we like better.
- Siemens delivered record fiscal Q3 results, with orders up 14% to €27.9 billion, revenue up 8%
Xometry Q2 Earnings Call Highlights
Key Points
- Interested in Xometry, Inc.? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 41% year over year to $229 million, while marketplace revenue increased 45% to
Siemens Healthineers Q3 Earnings Call Highlights
Siemens Healthineers (ETR:SHL) lowered its fiscal 2026 revenue growth outlook after continued weakness in its Diagnostics business, while